[Characteristics of dilzem treatment of patients with ischemic heart disease].
In 47 patients with coronary heart disease, the function of platelet was studied and ECG ST-segment was monitored. It was found that lower platelet function was more common in patients with severe coronary heart disease if they had long episodes of transient myocardial ischemia. Following 12 days of dilzem monotherapy, the most marked ++anti-ischemic and antianginal effects were observed in patients who had had higher platelet function.
Zharov
E I
EI
Styrova
T K
TK
Martynov
A I
AI
Barinov
V G
VG
Makarovskiĭ
V V
VV
Vertkin
A L
AL
Sedov
V P
VP
Galichenko
I V
IV
D000328:Adult; D000368:Aged; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy*; D004110:Diltiazem / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects / Q000502:physiology; D010975:Platelet Aggregation Inhibitors; D010979:Platelet Function Tests
D010975:Platelet Aggregation Inhibitors; D004110:Diltiazem
Osobennosti lecheniia dilzemom bol'nykh ishemicheskoĭ bolezn'iu serdtsa.